Although relatively rare, the heterozygous genotype of these PVR SNPs (no homozygous minor allele genotype was observed) was consistently associated with a significant decrease (> 2-fold) in neutralizing antibody titers after rubella vaccination in both cohorts. This evidence concerns the gene PVR and rubella.